Evaluation of an ambulatory care pathway for patients with nitrous oxide-induced myeloneuropathy
Evaluation of an ambulatory care pathway for patients with nitrous oxide-induced myeloneuropathy
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
IntroductionCases of nitrous oxide (N2O)-induced myeloneuropathy are increasing at UK hospitals. At our centre, a dedicated ambulatory care pathway, endorsed nationally, was established to treat and monitor patients with N2O-myeloneuropathy in 2021 and refined through three audit cycles. We analysed the outcomes of patients on this pathway to bette...
Alternative Titles
Full title
Evaluation of an ambulatory care pathway for patients with nitrous oxide-induced myeloneuropathy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d9cad045390c4343aada0d80b4e020cc
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d9cad045390c4343aada0d80b4e020cc
Other Identifiers
ISSN
2632-6140
E-ISSN
2632-6140
DOI
10.1136/bmjno-2024-000737
